Urinary Catalytic Iron in Obesity
- 1 February 2011
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 57 (2), 272-278
- https://doi.org/10.1373/clinchem.2010.154757
Abstract
INTRODUCTION: Obesity precedes the development of many cardiovascular disease risk factors, including type 2 diabetes mellitus (DM), hypertension, and chronic kidney disease. Catalytic iron, which has been associated with these chronic diseases, may be one of the links between obesity and these multifactorial diverse disorders. OBJECTIVE: We investigated whether urinary catalytic iron is increased in obese individuals without DM and overt kidney disease. STUDY DESIGN: We measured urinary catalytic iron using established methods in 200 randomly selected individuals without DM [100 who were obese (body mass index ≥30 kg/m2) and 100 who were nonobese (body mass index ≤27)]. Participants were selected from an outpatient clinic and community setting and were part of an ongoing cross-sectional study of obesity in individuals between the ages of 18 and 70 years. RESULTS: There was a significant difference in mean (95% CI) urinary catalytic iron excretion between the obese participants and the nonobese participants, 463 (343–582) nmol/mg [52.3 (38.8–65.8) nmol/μmol] vs 197 (141–253) nmol/mg [22.3 (15.9–28.6) nmol/μmol]; P < 0.001. The significant predictors of increased urinary catalytic iron were obesity (P = 0.001) and waist-to-hip ratio (P = 0.03). CONCLUSIONS: Our study results demonstrate that obesity and waist-to-hip ratio are associated with increased urinary catalytic iron, which may be a useful marker of oxidative stress. Additional studies are needed to determine the role of catalytic iron in increased cardiovascular disease and chronic kidney disease associated with obesity.Keywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD043451)
- National Institutes of Health (ACCORD, TINSAL-2D)
- American Diabetes Association
- Tullis-Tulane Chair of Diabetes
- Susan Harling Robinson Fellowship in Diabetes Research
- Tullis-Tulane Alumni Chair in Diabetes
This publication has 40 references indexed in Scilit:
- Serum catalytic iron as a novel biomarker of vascular injury in acute coronary syndromesEuroIntervention, 2009
- Iron in arterial plaque: A modifiable risk factor for atherosclerosisBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Cardiovascular Disease, Chronic Kidney Disease, and Type 2 Diabetes MellitusJournal of the American Society of Nephrology, 2008
- Inflammation and iron deficiency in the hypoferremia of obesityInternational Journal of Obesity, 2007
- Obesity and Diabetes in the Developing World — A Growing ChallengeThe New England Journal of Medicine, 2007
- Is Serum Ferritin an Additional Cardiovascular Risk Factor for All Postmenopausal Women?Annals of Nutrition and Metabolism, 2004
- OverviewJournal of the American Society of Nephrology, 2004
- Definition of Metabolic SyndromeCirculation, 2004
- Urinary iron speciation in nephrotic syndromeAmerican Journal of Kidney Diseases, 1995
- EditorialMethods, 1990